Biotech ONO PHARMA Announces Enrollment is Complete for the First Arm of the PROSPECT Study of Tirabrutinib in U.S. Patients with Relapsed or Refractory PCNSL March 25, 2024
Biotech First Patient Dosed in Italian Named Patient (Early Access) Program for TLX250-CDx, Telix’s Kidney Cancer Imaging Agent March 25, 2024
Biotech Advancing Healthcare Innovation: Juniper Biologics Recognized as the Best Novel Therapy R&D and Commercialization Company 2024 by APAC Insider March 25, 2024
Biotech Lipid Nanoparticle Raw Materials Market Worth $356.05 Mn by 2031 – Exclusive Report by InsightAce Analytic Pvt. Ltd. March 13, 2024
Biotech ProteoNic Announces Partnership with Ginkgo Bioworks and Joins the Ginkgo Technology Network March 13, 2024
Biotech Hummingbird Bioscience and Dartmouth’s Geisel School of Medicine to Co-Host 3rd Annual Virtual VISTA Symposium on March 27, 2024 March 13, 2024
Biotech ANEW MEDICAL ANNOUNCES KEY PATENT ISSUED IN CHINA TO PROTECT KLOTHO PROTEIN AND GENE DELIVERY SYSTEMS March 4, 2024
Biotech MGI Tech and Eurofins Genomics Partner to Elevate Precision Health with Revolutionary DNBSEQ-T20×2 Sequencer and Related Technologies March 4, 2024
Biotech Results from the Clinical Trial of Qilu Pharmaceutical’s Novel Anticancer Agent Iparomlimab and Tuvonralimab (QL1706) Featured in Oral Presentation at the ESGO Annual Meeting March 4, 2024
Biotech PeproMene Bio, Inc. Announces Complete Remission of the Cohort 1 First Patient Treated for Relapsed and Refractory B-cell Acute Lymphoblastic Leukemia (B-ALL) in the Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells) at City of Hope January 18, 2024
Search
Biotech
March 25, 2024
March 25, 2024
March 25, 2024
March 13, 2024
March 13, 2024
March 13, 2024
March 4, 2024
March 4, 2024
March 4, 2024
January 18, 2024
